Patient 3, exceeding the threshold by +0.10 at BRCA1, developed an invasive ductal carcinoma (estrogen and progesterone negative staining, HER2/neu positive staining, tumor size pT3, grade III, pN7/21) at the age of 28 years. Here, ERBB2 is linked to neoplasm.